NLRP3 and metabolic dysfunction-associated steatotic liver disease: Overall, there is compelling (preclinical) evidence (although some reports failed to show a convincing protective role of NLRP3 against MASH [70]) that inflammasomes are of crucial importance in MASLD and might especially be relevant in the evolution of fibrosis.